Archer Investment Corp »

Cyclacel Pharmaceuticals shares owned by Archer Investment Corp

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (BGMS) shares owned by Archer Investment Corp from 13F filings

Historical chart of Archer Investment Corp investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Archer Investment Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Archer Investment Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $5 1 5.00

More positions owned by Archer Investment Corp

First Trust Capital Etf Strength Etf (FTCS)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Invesco Exchange Traded Fd Tr S&p500 Eql Wgt Etf (RSP)
First Tr Viii Vest Etf U S Equity Moderate Buffer July Etf (GJUL)
Innovator Etfs Trust Equity Defined Protection Etf - 1 Yr Aug Etf (ZAUG)
First Tr Exch Trd Alphdx Fd Ii India Nfty50 Eqw Etf (NFTY)
Apple (AAPL)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded Fd Equity Premium Etf (JEPI)
Innovator Etfs Trust Us Eqt Ultra Bf Etf (UAUG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Prologis Reit (PLD)
JPMorgan Chase & Co. (JPM)

View all positions for Archer Investment Corp

Top funds holding Cyclacel Pharmaceuticals

Tower Research Capital
UBS Group
SBI Securities
Archer Investment Corp
Advisor Group Holdings

View all funds holding Cyclacel Pharmaceuticals